Zdrowie i gospodarka · 31/10/2017

FDA Requests Public Comment on Proposed Collection of Information for Postmarketing Adverse Event Reporting During Influenza Pandemic

The Food and Drug Administration is seeking public input on a proposed collection of information related to postmarketing adverse event reporting for medical products and dietary supplements during an influenza pandemic, as required by the Paperwork Reduction Act of 1995.